Tens of thousands of men each year with prostate cancer seek treatments that impact their quality of life with significant risks of urinary or sexual dysfunction. At Avenda Health, we believe patients should not have to choose between treating their prostate cancer and keeping their quality of life.
The Avenda Health platform delivers targeted treatment through focal laser ablation, which minimizes impact to healthy tissue. When compared to competing technologies, this ‘male lumpectomy’ is relatively inexpensive (no operating room), simple (local anesthesia), and requires no downtime for patients.
Avenda Health was voted the "most promising focal therapy" by leading urologists.
The Avenda Health platform delivers targeted treatment through focal laser ablation, which minimizes impact to healthy tissue. When compared to competing technologies, this ‘male lumpectomy’ is relatively inexpensive (no operating room), simple (local anesthesia), and requires no downtime for patients.
Avenda Health was voted the "most promising focal therapy" by leading urologists.
Location: United States, California, Santa Monica
Employees: 11-50
Total raised: $10M
Founded date: 2017
Investors 2
| Date | Name | Website |
| 25.02.2022 | VCapital | vcapital.c... |
| 16.12.2020 | UCLA Ventu... | ventures.u... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.09.2022 | Series B | $10M | - |
Mentions in press and media 16
| Date | Title | Description |
| 26.07.2024 | CMS Establishes National Payment for AI Prostate Cancer Mapping | What You Should Know: – Avenda Health, a pioneer in AI-powered prostate cancer care, announced today that the Centers for Medicare & Medicaid Services (CMS) has assigned a national payment rate for its prostate cancer mapping technology... |
| 15.06.2023 | New Stanford Research Study Provides Further Evidence for Personalized Prostate Cancer Mapping Using Machine Learning | Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, announced the results of a new study, “Prediction and Visualization of Lesion Extent in Intermediate-Risk Prostate Cancer using Artificial Int... |
| 11.12.2022 | Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance | Care models for prostate cancer desperately need personalization, declared Shyam Natarajan, co-founder and CEO of Avenda Health. To address this issue, his Culver City, California-based company built an AI-powered cancer management platform... |
| 08.12.2022 | First AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuestTM, Receives FDA Clearance | Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, announced its cancer management platform, iQuest, has received 510(k) clearance by the US Food and Drug Administration (FDA). iQuest combines ... |
| 07.12.2022 | Avenda recieves FDA clearance for its its personalized cancer management platform | This comes a few months after it raised a $10 million Series B round of funding Avenda Health is a company that creates personalized prostate cancer treatment. Its cloud-based platform, iQuest, leverages a patient’s own diagnostic informati... |
| 19.09.2022 | Avenda Health Raises $10M, Gets FDA Clearance To Begin Clinical Trial of Laser Heat Technology | - |
| 31.08.2022 | Avenda Health scores $10M to personalize prostate cancer care | The current standard of care for prostate cancer uses a one-size-fits-all approach, handling the cancer like a whole-gland disease even though prostate cancer is incredibly localized. That is the problem that Shyam Natarajan, co-founder and... |
| 26.08.2022 | Avenda Health Finds $10M For Prostate Cancer Treatment | Culver City-based Avenda Health, a startup using artificial intelligence in the healthcare area, said it has raised $10M in a Series B funding. The funding was led by VCapital, and also included Plug & Play Ventures and Wealthing VC Clu... |
| 26.08.2022 | Avenda Health raises $10M for personalized prostate cancer treatment | The company's AI uses a patient’s own diagnostic information to map prostate cancer About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and it's the second leading cause of cancer death in American men, behind onl... |
| 26.08.2022 | Avenda Health Raises $10M in Series B Funding | Avenda Health, a Culver City, CA-based AI healthcare company, raised $10M in Series B funding. The round was led by VCapital with participation from Plug & Play Ventures and Wealthing VC Club. The company intends to use the funds to acc... |
Show more